COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • November 10th, 2020 • Aravive, Inc. • Pharmaceutical preparations • England and Wales
This Collaboration and License Agreement (the “Agreement”) is entered into as of November 6, 2020 (the “Effective Date”) by and between Aravive, Inc., a corporation organized and existing under the laws of Delaware and having a place of business at 3730 Kirby Drive, Suite 1200, Houston, Texas 77098 USA (“Aravive”), and 3D Medicines Inc., a corporation organized and existing under the laws of the Cayman Islands and having a place of business at Cricket Square, Hutchins Drive, P.O. Box 2681, Grand Cayman KY1-1111, Cayman Islands (“3D Medicines”). Aravive and 3D Medicines are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
